Showing results (21-30 of 406) with videos related to

Sort By:
Pageof 41
Oncotargets and Therapy|May 2, 2019
Durvalumab for the management of urothelial carcinoma: a short review on the emerging data and therapeutic potentialCapucine Baldini, Stéphane Champiat, Perrine Vuagnat, et al.
Expert Review of Anticancer Therapy|March 1, 2018
Durvalumab in urothelial cancersPernelle Lavaud, Zineb Hamilou, Yohann Loriot, et al.
Bulletin Du Cancer|December 17, 2011
[Chromosomal rearrangements and fusion genes in carcinoma]Christophe Massard, Nathalie Auger, Ludovic Lacroix, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2020
Coronavirus disease (COVID-19) outbreak and phase 1 trials: should we consider a specific patient management?Sophie Postel-Vinay, Christophe Massard, Jean-Charles Soria
The Lancet. Oncology|April 3, 2025
Innovative, early-phase clinical trials of drug-radiotherapy combinationsAntonin Levy, Christophe Massard, Stefan Michiels, et al.
Expert Review of Anticancer Therapy|August 28, 2015
ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancerKarim Fizazi, Laurence Albiges, Yohann Loriot, et al.
Bulletin Du Cancer|May 6, 2014
[Abiraterone acetate (AA): current guidelines of prescription of abiraterone]Emilie Boissier, Yohann Loriot, Stéphane Vignot, et al.
European Journal of Cancer (Oxford, England : 1990)|April 15, 2014
Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancerAntoine Angelergues, Denis Maillet, Aude Fléchon, et al.
ISRN Oncology|November 18, 2011
Pathway profiling and rational trial design for studies in advanced stage cervical carcinoma: a review and a perspectiveSusy M E Scholl, Gemma Kenter, Christian Kurzeder, et al.
Pageof 41